HKD 0.24
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 565.9 Million HKD | -14.3% |
2022 | 660.37 Million HKD | -17.86% |
2021 | 803.91 Million HKD | -12.55% |
2020 | 919.33 Million HKD | 354.26% |
2019 | 202.38 Million HKD | 75.73% |
2018 | 115.16 Million HKD | -0.48% |
2017 | 115.72 Million HKD | 54.15% |
2016 | 75.07 Million HKD | -67.33% |
2015 | 229.81 Million HKD | -23.98% |
2014 | 302.29 Million HKD | -47.99% |
2013 | 581.27 Million HKD | 2.85% |
2012 | 565.15 Million HKD | 118.13% |
2011 | 259.09 Million HKD | -39.22% |
2010 | 426.27 Million HKD | -0.2% |
2009 | 427.11 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q4 | 253.02 Million HKD | 0.0% |
2023 FY | 565.9 Million HKD | -14.3% |
2023 Q2 | 312.88 Million HKD | 0.0% |
2022 Q4 | 304.7 Million HKD | 0.0% |
2022 Q2 | 355.66 Million HKD | 0.0% |
2022 FY | 660.37 Million HKD | -17.86% |
2021 Q2 | 402.45 Million HKD | 0.0% |
2021 FY | 803.91 Million HKD | -12.55% |
2021 Q4 | 462.05 Million HKD | 0.0% |
2020 Q4 | 416.27 Million HKD | 0.0% |
2020 Q2 | 503.06 Million HKD | 0.0% |
2020 FY | 919.33 Million HKD | 354.26% |
2019 FY | 202.38 Million HKD | 75.73% |
2019 Q2 | 60.59 Million HKD | 0.0% |
2019 Q4 | 152.86 Million HKD | 0.0% |
2018 Q2 | 59.83 Million HKD | 0.0% |
2018 FY | 115.16 Million HKD | -0.48% |
2018 Q4 | 55.32 Million HKD | 0.0% |
2017 Q2 | 47.82 Million HKD | 0.0% |
2017 FY | 115.72 Million HKD | 54.15% |
2016 FY | 75.07 Million HKD | -67.33% |
2016 Q2 | 37.88 Million HKD | 0.0% |
2015 FY | 229.81 Million HKD | -23.98% |
2015 Q2 | 138.17 Million HKD | 0.0% |
2014 Q2 | 147.78 Million HKD | 0.0% |
2014 FY | 302.29 Million HKD | -47.99% |
2013 Q4 | 262.3 Million HKD | 0.0% |
2013 Q2 | 318.96 Million HKD | 0.0% |
2013 FY | 581.27 Million HKD | 2.85% |
2012 Q4 | 338.56 Million HKD | 139.63% |
2012 FY | 565.15 Million HKD | 118.13% |
2012 Q1 | 64.77 Million HKD | 0.0% |
2012 Q2 | 64.77 Million HKD | 0.0% |
2012 Q3 | 141.28 Million HKD | 118.13% |
2011 Q4 | 64.77 Million HKD | 0.0% |
2011 Q2 | 106.56 Million HKD | 0.0% |
2011 Q1 | 106.56 Million HKD | 0.0% |
2011 FY | 259.09 Million HKD | -39.22% |
2011 Q3 | 64.77 Million HKD | -39.22% |
2010 Q3 | 106.56 Million HKD | -0.2% |
2010 Q2 | 106.77 Million HKD | 0.0% |
2010 FY | 426.27 Million HKD | -0.2% |
2010 Q1 | 106.77 Million HKD | 0.0% |
2010 Q4 | 106.56 Million HKD | 0.0% |
2009 Q4 | 106.77 Million HKD | 0.0% |
2009 FY | 427.11 Million HKD | 0.0% |
2009 Q3 | 106.77 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -68.417% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -8483.437% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -212.664% |
Prosperous Future Holdings Limited | 470.33 Million HKD | -20.32% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | -111.14% |
Evergreen Products Group Limited | 979.24 Million HKD | 42.21% |
EC Healthcare | 4.21 Billion HKD | 86.561% |
Ming Fai International Holdings Limited | 2.06 Billion HKD | 72.625% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 92.273% |
SuperRobotics Holdings Limited | 15.08 Million HKD | -3652.443% |
Takbo Group Holdings Limited | 215.59 Million HKD | -162.491% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | 34.672% |